Zhangjun Cheng
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Surgery 32
- Cholangiocarcinoma and Gallbladder Cancer Studies 26
-
- Circular RNAs in diseases 6
- Co-authors
- Yong Xia (9 shared papers)Jiahua Zhou (11 shared papers)Feng Shen (11 shared papers)Kui Wang (7 shared papers)Pinghua Yang (16 shared papers)Anfeng Si (15 shared papers)Zhengqing Lei (18 shared papers)Norbert Hüser (16 shared papers)
In The Last Decade
Zhangjun Cheng
60 papers receiving 1.4k citations
Zhangjun Cheng's Hit Papers
Peers
Comparison fields: 5 of 96
- Hepatology 452
- Cancer Research 474
- Oncology 296
- Surgery 396
- Molecular Biology 560
Countries citing papers authored by Zhangjun Cheng
This map shows the geographic impact of Zhangjun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhangjun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhangjun Cheng more than expected).
Fields of papers citing papers by Zhangjun Cheng
This network shows the impact of papers produced by Zhangjun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhangjun Cheng. The network helps show where Zhangjun Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhangjun Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription Hit paper breakdown → | 2021 | 171 |
| 2 | 2014 | 133 | |
| 3 | 2019 | 121 | |
| 4 | 2021 | 95 | |
| 5 | 2021 | 80 | |
| 6 | 2018 | 71 | |
| 7 | 2019 | 61 | |
| 8 | 2015 | 51 | |
| 9 | 2015 | 48 | |
| 10 | 2018 | 37 | |
| 11 | 2019 | 37 | |
| 12 | 2019 | 33 | |
| 13 | 2016 | 32 | |
| 14 | 2021 | 31 | |
| 15 | 2022 | 30 | |
| 16 | 2019 | 25 | |
| 17 | 2023 | 21 | |
| 18 | 2023 | 21 | |
| 19 | 2023 | 21 | |
| 20 | 2019 | 20 |
About Zhangjun Cheng
Zhangjun Cheng is a scholar working on Surgery, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 65 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers), Cancer-related molecular mechanisms research (13 papers), Gallbladder and Bile Duct Disorders (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), MicroRNA in disease regulation (8 papers), Liver Disease Diagnosis and Treatment (8 papers), Viral-associated cancers and disorders (7 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Hepatology (452 citations), Cancer Research (474 citations), Oncology (296 citations), Surgery (396 citations) and Molecular Biology (560 citations). Zhangjun Cheng has collaborated with scholars based in China, Germany and Hong Kong. Frequent co-authors include Yong Xia, Jiahua Zhou, Feng Shen, Kui Wang, Pinghua Yang, Anfeng Si, Zhengqing Lei, Norbert Hüser, Jun Li and Wan Yee Lau. Their work appears in journals such as HPB, BMC Cancer, Frontiers in Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.